Literature DB >> 9591205

Consistency in maintaining contact with HIV-related service providers: an analysis of the AIDS Cost and Services Utilization Study (ACSUS).

S J Niemcryk1, A Bedros, K M Marconi, J F O'Neill.   

Abstract

Patients (n = 1949) infected with HIV were recruited for the AIDS Cost & Service Utilization Survey (ACSUS) from ten U.S. cities and administered face to face interviews at three month intervals over an 18 month period from March 1, 1991 to August 31, 1992. The interview was designed to obtain information at each wave of data collection on the use of the following services: ambulatory care, hospitalization, emergency room use, support groups/counseling, drug and alcohol treatment, and dental care. Patients were found to be highly consistent in their patterns of utilization across time, regardless of the service in question. Of the patients who reported using an emergency room (ER) at Time 1, 52% also reported using an ER during the next three months later at Time 2. Of those who reported having been hospitalized during the Time 1 reporting period, almost 58% reported a hospitalization again at Time 2. Next, use of a service at Time 6 (n = 1404, 72.2%) was regressed onto whether the person received the service at Time 2 and the personal, financial, and medical variables. Except for dental services, utilization of a service one year in the past (Time 2) was the strongest predictor of Time 6 use. The findings indicated that the one factor consistently related to service use within this sample is a factor (as opposed to education, race, or even insurance) that is amenable to intervention: previous use of that service. The individuals studied established patterns of service utilization that are of reasonably long duration once they began use of a service. This continuity of care becomes more critical as the initiation of treatments begins with the diagnosis of HIV rather than AIDS. Findings suggest that HIV outreach efforts be targeted to increasing early use of medical and behavioral services in ambulatory care settings.

Entities:  

Mesh:

Year:  1998        PMID: 9591205     DOI: 10.1023/a:1018713524788

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  16 in total

1.  Variation in health service use among HIV-infected patients.

Authors:  V Mor; J A Fleishman; M Dresser; J Piette
Journal:  Med Care       Date:  1992-01       Impact factor: 2.983

2.  Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. North American Lamivudine HIV Working Group.

Authors:  A N Phillips; J Eron; J Bartlett; D R Kuritzkes; V A Johnson; C Gilbert; J Johnson; A Keller; A M Hill
Journal:  AIDS       Date:  1997-02       Impact factor: 4.177

3.  Sex, drugs and HIV counseling and testing: a prospective study of behavior-change among methadone-maintenance clients in New England.

Authors:  R J MacGowan; R M Brackbill; D L Rugg; N M Swanson; B Weinstein; A Couchon; J Scibak; S Molde; P McLaughlin; T Barker; R Voigt
Journal:  AIDS       Date:  1997-02       Impact factor: 4.177

Review 4.  HIV-1 protease inhibitors. A review for clinicians.

Authors:  S G Deeks; M Smith; M Holodniy; J O Kahn
Journal:  JAMA       Date:  1997-01-08       Impact factor: 56.272

5.  Costs to Medicaid of advancing immunosuppression in an urban HIV-infected patient population in Maryland.

Authors:  R D Moore; R E Chaisson
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-03-01

6.  First 500,000 AIDS cases--United States, 1995.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-11-24       Impact factor: 17.586

7.  Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.

Authors:  A C Collier; R W Coombs; D A Schoenfeld; R L Bassett; J Timpone; A Baruch; M Jones; K Facey; C Whitacre; V J McAuliffe; H M Friedman; T C Merigan; R C Reichman; C Hooper; L Corey
Journal:  N Engl J Med       Date:  1996-04-18       Impact factor: 91.245

8.  Correlates of medical service utilization among people with HIV infection.

Authors:  J A Fleishman; D C Hsia; F J Hellinger
Journal:  Health Serv Res       Date:  1994-12       Impact factor: 3.402

9.  Initial and repeat mammography screening in a low income multi-ethnic population in Los Angeles.

Authors:  R Bastani; C P Kaplan; A E Maxwell; R Nisenbaum; J Pearce; A C Marcus
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1995-03       Impact factor: 4.254

10.  Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons.

Authors:  M D Stein; J Piette; V Mor; T J Wachtel; J Fleishman; K H Mayer; C C Carpenter
Journal:  J Gen Intern Med       Date:  1991 Jan-Feb       Impact factor: 5.128

View more
  3 in total

1.  Economic analysis of initial HIV treatment. Efavirenz- versus indinavir-containing triple therapy.

Authors:  J J Caro; J A O'Brien; K Migliaccio-Walle; G Raggio
Journal:  Pharmacoeconomics       Date:  2001-01       Impact factor: 4.981

2.  Outpatient treatment entry and health care utilization after a combined medical/substance abuse intervention for hospitalized medical patients.

Authors:  Thomas P O'Toole; Eric C Strain; Gary Wand; Mary E McCaul; Matthew Barnhart
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

3.  Changing trends of HIV-related hospitalizations: a small area analysis in Illinois, 1994-2000.

Authors:  Mary Jean Brown; Meridith Eastman; Edmond D Shenassa
Journal:  J Community Health       Date:  2003-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.